AUA Guideline on Management of Benign Prostatic Hyperplasia (2003). Chapter 1: Diagnosis and Treatment Recommendations

This publication has 77 references indexed in Scilit:

• Treatment of Benign Prostatic Hyperplasia with Water-Induced Thermotherapy: Experience of a Single Institution
  Journal of Endourology, 2002
• Office-Based Transurethral Microwave Thermotherapy Using the TherMatrx TMx-2000
  Journal of Endourology, 2002
• DIGITAL RECTAL EXAMINATION FOR DETECTING PROSTATE CANCER AT PROSTATE SPECIFIC ANTIGEN LEVELS OF 4 NG./ML. OR LESS
  Journal of Urology, 1999
• THE IMPACT OF MEDICAL THERAPY ON BOTHER DUE TO SYMPTOMS, QUALITY OF LIFE AND GLOBAL OUTCOME, AND FACTORS PREDICTING RESPONSE
  Journal of Urology, 1998
• Using the ICSQoL to measure the impact of lower urinary tract symptoms on quality of life: evidence from the ICS–‘BPH’ study
  British Journal of Urology, 1997
• Clinical comparison of selective and non‐selective &agr;₁A‐adrenoreceptor antagonists in benign prostatic hyperplasia: studies on tamsulosin in a fixed dose and terazosin in increasing doses
  British Journal of Urology, 1997
• High-Intensity Focused Ultrasound Energy for Benign Prostatic Hyperplasia: Clinical Response at 6 Months to Treatment Using Sonablate 200™
  Journal of Endourology, 1997
• A Comparison of Transurethral Surgery with Watchful Waiting for Moderate Symptoms of Benign Prostatic Hyperplasia
  New England Journal of Medicine, 1995
• Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer
  New England Journal of Medicine, 1991
• Clinical decision making: from theory to practice. Guidelines for policy statements: the explicit approach
  Published by American Medical Association (AMA) ,1990